Aarkstore - Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 PowerPoint presentation | free to download - id: 708a69-YThlZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Description:

Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Malaria. Browse full report @ – PowerPoint PPT presentation

Number of Views:26

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015


1
Aarkstore - Malaria-Global API Manufacturers,
Marketed and Phase III Drugs Landscape, 2015
Category Pharmaceuticals and Healthcare
2
Malaria-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2015, Report provides
comprehensive insights about phase III pipeline
drugs and marketed drugs across the Malaria. A
key objective of DelveInsights report is to
establish the understanding for API Manufacturers
for marketed and Phase III Pipeline drugs across
the different countries and regions for the drugs
falling under Malaria. The Report gives insights
into patents providing the patent protection data
and marketing exclusivity of all the drugs across
the Malaria. While the leading brands, companies
and chemicals are considered thoroughly,
DelveInsights report also provides details on the
Global API Manufacturers across the globe
covering Drug Master Filings of US, Europe and
API Manufacturers in Asia specifically China and
India. The research analysis also presents the
global sales forecasts data till 2016.
Browse Complete Report http//www.aarkstore.com
/pharmaceuticals-healthcare/97794/malaria-global-a
pi-manufacturers-marketed-and-phase-iii-drugs-land
scape-2015
3
Data Sources
  • The report is built using data and information
    sourced from proprietary databases, primary and
    secondary research and in-house analysis by
    DelveInsight team of industry experts.
  • Secondary sources information and data has been
    collected from various printable and
    non-printable sources like search engines, News
    websites, Government Websites, Trade Journals,
    White papers, Magazines, Trade associations,
    Books, Industry Portals, Industry Associations
    and access to available databases.
  • Please noteThis report requires certain updates.
    We have all the information available but require
    3 business days to complete the process and
    ensure it is as up-to-date as possible. Certain
    sections in the report may be removed or altered
    based on the availability and relevance of data
    for the indicated disease.

4
Scope
  • A snapshot of the global Market therapeutics
    scenario for Malaria.
  • A review of the marketed products under
    prescription for Malaria, regulatory information
    and marketing status.
  • Coverage of global patent coverage and detailed
    commentaries on the US patent challenges.
  • Graphical representation of investigational
    products for patent expiry and market
    exclusivities across the globe.
  • Product profiles for marketed products for
    Malaria with complete description of mechanism of
    action, therapeutic class, target, route(s) of
    administration and chemical details.
  • Coverage of API Manufacturers for Malaria drugs
    in the United States, Europe and Asian Regions
    with location details.
  • Coverage of Regulatory filings in theUS, Europe,
    and Asia specifically India and China for Malaria
    drugs.

5
Reasons to buy
  • Evaluate the marketing status and exclusivity
    details of Malariakey products to exploit
    opportunities for generic drug development
    opportunities.
  • Identify and understand important and diverse
    types of therapeutics under Phase III development
    for Malaria.
  • Design effective counter-strategies to gain
    competitive advantage by identifying the key
    patent expiry details and exclusivity with
    respect to Malaria.
  • API intelligence over marketed drugs
    forMalariaand gaining primary intelligence over
    active ingredients manufacturers across the
    globe.
  • API intelligence over leading Phase III Pipeline
    drugs.
  • Develop and designstrategies by identifying the
    API manufacturers for Phase III Pipeline products
    to enhance and expand business potential and
    scope.

6
Table of Content
  • Indication Overview
  • Marketed Drugs
  • Marketed Details of Drugs by Application Type
  • Marketed Details of Drugs (NDA) by Marketing
    Status
  • Marketed Details of Drugs by Patent Expiration
    Timeline
  • Active Pharmaceutical Ingredient (API)
    Manufacturers Assessment
  • API Manufacturers by United States Drug Master
    File (US DMF) Status
  • API Manufacturers by US DMF Status (Drug
    Specific)
  • API Manufacturers in Europe by Country
  • API Manufacturers in India by State
  • API Manufacturers in China by Province
  • Marketed Details of Approved Drugs by Geography
  • Active Pharmaceutical Ingredient (API)
    Manufacturers Assessment for Phase III Pipeline
    Drugs

7
List of Tables
  • Malaria Therapeutic Market, US, Marketed Drugs by
    Application Type, 2015
  • Malaria Therapeutic Market, US, Marketed Drugs by
    Marketing Status, 2015
  • Malaria Therapeutic Market, US, (Year), 2015
  • Malaria Marketed Drugs, API Manufacturers by US
    DMF Status, 2015
  • Malaria Marketed Drugs, US DMF Status Drug
    Specific (Number), 2015
  • Malaria Drugs, API Manufacturers, Europe by
    Country, 2015
  • Malaria Drugs, API Manufacturers, India by State,
    2015
  • Malaria Drugs, API Manufacturers, China by
    Province, 2015
  • Malaria Drugs, API Manufacturers by Geography
    2015
  • Malaria Phase III Pipeline Drugs, US DMF Status
    Drug Specific (Number), 2015
  • Malaria Therapeutic Market, Global Sales
    2012-2016 (in million USD)
  •  
  •  

8
List Of Figures
  • Malaria Therapeutic Market, US, Marketed Drugs by
    Application Type (), 2015
  • Malaria Therapeutic Market, US, Marketed Drugs by
    Marketing Status (), 2015
  • Malaria Therapeutic Market, US, (Year), 2015
  • Malaria Marketed Drugs, API Manufacturers by US
    DMF Status (), 2015
  • Malaria Marketed Drugs, US DMF Status Drug
    Specific (Number), 2015
  • Malaria Drugs, API Manufacturers, Europe by
    Country, 2015
  • Malaria Drugs, API Manufacturers, India by State,
    2015
  • Malaria Drugs, API Manufacturers, China by
    Province, 2015
  • Malaria Drugs, API Manufacturers by Geography
    2015
  • Malaria Phase III Pipeline Drugs, US DMF Status
    Drug Specific (Number), 2015
  • Malaria Therapeutic Market, Global Sales
    2012-2016 (in million USD)
  • Drug, Patent/Exclusivity Expiry (Year), 2015
  •  

9
Related reports
  • China pharmaceutical special equipment
    manufacturing industry, 2015
  • China printing, pharmaceutical, and everyday
    chemical special equipment manufacturing
    industry, 2015
  • Weight Loss and Weight Management Market by
    Equipment (Fitness Equipment (Treadmill, Stair
    Steppers)), Surgical Equipment (Adjustable
    Gastric Band, Gastric Bypass), Diet (Weight Loss
    Meals, Diet Soft Drinks), Weight Loss Services -
    Forecast to 2019
  • Animal Health Market 2015 Global Trends and
    Strategies of Key Suppliers
  • 2015 World Animal Health Market Outlook and
    Leading Supplier Strategies, Marketing Tactics,
    and Technological Know-How
  •  
  • Global Ultrasound Equipment Market 2015-2019
  • Cystic Fibrosis Market in Europe 2015-2019
  • Global Cell Culture Protein Surface Coating
    Market 2015-2019
  • Generic Drugs Market in Japan 2015-2019
  • Lupus Erythematosus-Global API Manufacturers,
    Marketed and Phase III Drugs Landscape, 2015

10
  • Malaria-Global API Manufacturers, Marketed and
    Phase III Drugs Landscape, 2015
  • Published Feb 2015 100 Pages
  • Malaria-Global API Manufacturers, Marketed and
    Phase III Drugs Landscape, 2015, Report provides
    comprehensive insights about phase III pipeline
    drugs and marketed drugs across the Malaria.
  • Price

Format Price
PDF 2000
Site License 4000
Enterprise Wide License 6000
11
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com